AbbVie
ABBV
#29
Rank
$326.96 B
Marketcap
$185.16
Share price
1.64%
Change (1 day)
30.49%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$37.03 M-83.84%
2023$0.22 B-63.52%
2022$0.62 B629.28%
2021$86.13 M-77.97%
2020$0.39 B85.64%
2019$0.21 B-52.97%
2018$0.44 B269.88%
2017$0.12 B-48.45%
2016$0.23 B-37.53%
2015$0.37 B-44.13%
2014$0.67 B2387.79%
2013$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$0.10 B$0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
$53.33 M$0.30 B๐Ÿ‡บ๐Ÿ‡ธ USA
$28.3 M$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
$64.53 M$0.23 B๐Ÿ‡บ๐Ÿ‡ธ USA
$8.76 M$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
$21.43 M$81.86 M๐Ÿ‡บ๐Ÿ‡ธ USA
$8.47 M$28.63 M๐Ÿ‡ฌ๐Ÿ‡ง UK
$12.74 M$0.13 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.52 M$32.36 M๐Ÿ‡บ๐Ÿ‡ธ USA